The occurrence of a myocardial infarction (MI) in the absence of obstructive coronary artery disease (CAD) is a well-recognized clinical entity known as MINOCA (Myocardial Infarction with Non-Obstructive
Cardiac rupture is a catastrophic complication typically occurring after a myocardial infarction (MI). It often involves a full-thickness tear of the myocardium, leading to the escape of blood
Reperfusion injury, the paradoxical damage caused when blood flow is restored to previously ischemic tissue, remains one of the most significant hurdles in cardiology and stroke management. While
Based on the most recent clinical trial data and guidelines, the role of the Intra-Aortic Balloon Pump (IABP) has shifted from a primary, routine therapy to a highly
Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes is a novel non-invasive therapy which has been evaluated in two recent clinical trials. Low-level electrical stimulation of
Rotablator (Rotational Atherectomy System) is a specialized tool used to “drill” through heavy calcium deposits within coronary arteries. While a standard angioplasty uses a balloon to stretch an
Multi-site Left Ventricular (LV) pacing is an advanced evolution of Cardiac Resynchronization Therapy (CRT). While standard CRT uses a single lead in a tributary of the coronary sinus
The STORM-PE (Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism) trial is a landmark study that provides evidence for
The non-pharmacological management of atrial fibrillation has evolved into a comprehensive “fourth pillar” of care, alongside anticoagulation, rate control, and rhythm control. Emphasis is on early intervention and
Coarctoplasty (also known as Balloon Angioplasty for Coarctation of the Aorta) is a minimally invasive procedure used to treat a coarctation of aorta. Earlier the term was used
